Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Presence of Mycotoxins in Milk Thistle (Silybum marianum) Food Supplements: A Review

D. Pickova, V. Ostry, J. Toman, F. Malir

. 2020 ; 12 (12) : . [pub] 20201208

Language English Country Switzerland

Document type Journal Article, Research Support, Non-U.S. Gov't, Review

Grant support
2112/2019 Specific research project, Faculty of Science, University of Hradec Kralove - International
National Institute of Public Health-NIPH, IN 75010330 Ministry of Health, Czech Republic-conceptual development of research organization - International

The consumption of herbal-based supplements, which are believed to have beneficial effects on human health with no side effects, has become popular around the world and this trend is still increasing. Silybum marianum (L.) Gaertn, commonly known as milk thistle (MT), is the most commonly studied herb associated with the treatment of liver diseases. The hepatoprotective effects of active substances in silymarin, with silybin being the main compound, have been demonstrated in many studies. However, MT can be affected by toxigenic micro-fungi and contaminated by mycotoxins with adverse effects. The beneficial effect of silymarin can thus be reduced or totally antagonized by mycotoxins. MT has proven to be affected by micro-fungi of the Fusarium and Alternaria genera, in particular, and their mycotoxins. Alternariol-methyl-ether (AME), alternariol (AOH), beauvericin (BEA), deoxynivalenol (DON), enniatin A (ENNA), enniatin A1 (ENNA1), enniatin B (ENNB), enniatin B1 (ENNB1), HT-2 toxin (HT-2), T-2 toxin (T-2), tentoxin (TEN), and zearalenone (ZEA) seem to be most significant in MT-based dietary supplements. This review focuses on summarizing cases of mycotoxins in MT to emphasize the need for strict monitoring and regulation, as mycotoxins in relation with MT-based dietary supplements are not covered by European Union legislation.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019677
003      
CZ-PrNML
005      
20210830101250.0
007      
ta
008      
210728s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/toxins12120782 $2 doi
035    __
$a (PubMed)33302488
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Pickova, Darina $u Department of Biology, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, CZ-50003 Hradec Kralove, Czech Republic
245    10
$a Presence of Mycotoxins in Milk Thistle (Silybum marianum) Food Supplements: A Review / $c D. Pickova, V. Ostry, J. Toman, F. Malir
520    9_
$a The consumption of herbal-based supplements, which are believed to have beneficial effects on human health with no side effects, has become popular around the world and this trend is still increasing. Silybum marianum (L.) Gaertn, commonly known as milk thistle (MT), is the most commonly studied herb associated with the treatment of liver diseases. The hepatoprotective effects of active substances in silymarin, with silybin being the main compound, have been demonstrated in many studies. However, MT can be affected by toxigenic micro-fungi and contaminated by mycotoxins with adverse effects. The beneficial effect of silymarin can thus be reduced or totally antagonized by mycotoxins. MT has proven to be affected by micro-fungi of the Fusarium and Alternaria genera, in particular, and their mycotoxins. Alternariol-methyl-ether (AME), alternariol (AOH), beauvericin (BEA), deoxynivalenol (DON), enniatin A (ENNA), enniatin A1 (ENNA1), enniatin B (ENNB), enniatin B1 (ENNB1), HT-2 toxin (HT-2), T-2 toxin (T-2), tentoxin (TEN), and zearalenone (ZEA) seem to be most significant in MT-based dietary supplements. This review focuses on summarizing cases of mycotoxins in MT to emphasize the need for strict monitoring and regulation, as mycotoxins in relation with MT-based dietary supplements are not covered by European Union legislation.
650    _2
$a zvířata $7 D000818
650    _2
$a potravní doplňky $x škodlivé účinky $x analýza $7 D019587
650    _2
$a Evropská unie $7 D005062
650    _2
$a lidé $7 D006801
650    _2
$a ostropestřec mariánský $x škodlivé účinky $7 D020944
650    _2
$a mykotoxiny $x škodlivé účinky $x analýza $7 D009183
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Ostry, Vladimir $u Department of Biology, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, CZ-50003 Hradec Kralove, Czech Republic $u Center for Health, National Institute of Public Health in Prague, Nutrition and Food in Brno, Palackeho 3a, CZ-61242 Brno, Czech Republic
700    1_
$a Toman, Jakub $u Department of Biology, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, CZ-50003 Hradec Kralove, Czech Republic
700    1_
$a Malir, Frantisek $u Department of Biology, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, CZ-50003 Hradec Kralove, Czech Republic
773    0_
$w MED00177194 $t Toxins $x 2072-6651 $g Roč. 12, č. 12 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33302488 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830101250 $b ABA008
999    __
$a ok $b bmc $g 1690482 $s 1140123
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 12 $c 12 $e 20201208 $i 2072-6651 $m Toxins $n Toxins $x MED00177194
GRA    __
$a 2112/2019 $p Specific research project, Faculty of Science, University of Hradec Kralove $2 International
GRA    __
$a National Institute of Public Health-NIPH, IN 75010330 $p Ministry of Health, Czech Republic-conceptual development of research organization $2 International
LZP    __
$a Pubmed-20210728

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...